Form D · Biotechnology

ImmPACT Bio USA Inc.

West Hills, CA · CIK 0001820064

Offering snapshot reported Apr 2, 2024 · SEC filing

Reported sold: $140M
Investors reported: 15
Minimum accepted: $0
First sale: Jan 14, 2022

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$110,855,843 → $139,855,923
Reported investors13 → 15

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Apr 2, 2024	Amendment	$139,855,923	$29,000,080vs Jan 20, 2022	15	SEC filing
Jan 20, 2022	Initial	$110,855,843	No comparison	13	SEC filing
Aug 5, 2020	Initial	$3,750,000	No comparison	17	SEC filing

Offering details

Securities: Equity
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $0
Finders' fees: $0
Form D file number: 021-430160

Source: Form D, filed Apr 2, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Yvonne Yu Hsuan Chen	Director
Erez Chimovits	Director
Xiangmin Cui	Director
Sheila Guirathi	Director
Richard Kendall	Director, Executive
Assaf Keret	Director
Han Lee	Executive
Anat Nursella	Executive
Sumant Ramachandra	Director, Executive
Michal Silverberg	Director
Robbie Woodman	Director
Asish Xavier	Director
Cindy Xiong	Director
Yvonne Yamanaka	Director
David Zigdon	Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:

8501 Fallbrook Avenue Suite 200
West Hills, CA, 91304